# Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study

> **NCT06161415** · PHASE1 · RECRUITING · sponsor: **Quan Dong Nguyen** · enrollment: 12 (estimated)

## Conditions studied

- Inflammation
- Uveitis

## Interventions

- **DRUG:** Laquinimod eye drops

## Key facts

- **NCT ID:** NCT06161415
- **Lead sponsor:** Quan Dong Nguyen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-03
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06161415

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06161415, "Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06161415. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*